Multiple Manufacturers

CAMPTOSAR

Manufacturer:

Multiple Manufacturers

Camptosar HCPCS:

J9206

HCPCS Code Descriptor:

Injection, irinotecan, 20 mg

Category:

J Code

Camptosar NDCs:

50742-0401-02, 60505-6272-01, 61703-0349-16, 72485-0211-02, 55150-0352-01, 70700-0169-22, 68001-0480-35, 16714-0027-01, 60505-6128-00, 00143-9702-01, 72485-0212-05, 63323-0193-52, 00143-9583-01, 25021-0230-02, 50742-0402-05, 45963-0614-51, 61703-0349-09, 16714-0131-01, 70700-0170-22, 55150-0353-01, 00009-7529-04, 68001-0480-22, 60505-6128-01, 45963-0614-55, 25021-0230-05, 23155-0179-31, 63323-0193-55, 00143-9701-01, 72485-0213-15, 00009-7529-03, 00009-1111-02, 55150-0354-01, 23155-0179-32, 61703-0349-36, 00009-7529-05

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

23155-0179-31, 00009-1111-02, 23155-0179-32

About Camptosar:

CAMPTOSAR is a medication manufactured by multiple manufacturers and aligned to the J Code: J9206. CAMPTOSAR is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9206 Added Date:

January 1, 1998

J9206 Effective Date:

January 1, 2009

J9206 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Camptosar billing and coding information.
Our team did not identify a source for Camptosar patient assistance information. Please reach out to our team if you feel that this is a mistake.
CAMPTOSAR prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for CAMPTOSAR. Please check back in a few weeks.